Beroni Group appoints Dr Richard Buchta to its Board as Independent Director

– AUSTRALIA, Sydney –  Beroni Group Limited (OTC: BNIGF | NSX: BTG), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for the treatment of global diseases, today announced the appointment of Dr.